Omalizumab boosts tolerance to multiple food allergies, study finds

A study in The New England Journal of Medicine shows omalizumab increases allergen tolerance in individuals with multiple food allergies, offering a promising standalone treatment option.

Numinus Announces Partnership with MAPS to Support Therapist Psychedelic Experiential Training – Psychedelic Alpha

Numinus has submitted a Clinical Trial Application (CTA) to Health Canada to enable MDMA-assisted therapy Experiential Opportunities for practitioners as part of an investigational Phase

June 15, 2023

Bluebird Bio is laying off 25% of its workers to cut costs

Gene therapy company Bluebird Bio on Tuesday announced a 25% reduction of its workforce as part of a restructuring meant to save money as it

September 24, 2024

BP Tracking Undergarment; COPD Exacerbations & HF Events; Hemolysis After PFA

The FDA cleared the algorithm for continuous blood pressure monitoring for the SimpleSense wearable garment, Nanowear announced. (FierceBiotech) Occlutech announced FDA approval of its ASD

January 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.